XTL Biopharmaceuticals Ltd

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
XTL Biopharmaceuticals Ltd
TickerXTLB
CIK #0001023549
CUSIP98386D307
SectorLife Sciences - Pharmaceutical Preparations
AddressXtl Biopharmaceuticals Ltd c/o Alston & Bird Llp, 90 Park Avenue, New York, NY 10016
Source [EDGAR]
CIK Filing 2011 - 2025
[0001023549] 6-K
[0001023549] D
[0001023549] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Intracoastal Capital LLC XTL Biopharmaceuticals Ltd [2017-02-27] 0.7
Sabby Management LLC XTL Biopharmaceuticals Ltd [2015-04-02] 4.87
Form 13F Holdings
Firm Period DFND Voting Shares
Noked Israel Ltd [2025-06-30] DFND 198,888 198,888
RhumbLine Advisers [2025-06-30] SOLE 17,261 17,261
Morgan Stanley [2025-06-30] DFND 11,011 11,011
UBS Group AG [2025-06-30] DFND 1,336 1,336
Concourse Financial Group Securities Inc [2025-06-30] SOLE 0 0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com